| Deler fremragende | 47,196,564 shares |
| Insideraktier | 31.210.761 shares |
| Insider ejerskab | 66,13 % |
| Total Insiders | 33 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Whitehawk Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Behzad Aghazadeh
Director, 10% Owner -
[D]
|
3.471.752 | 3.471.752 | |
| Avoro Ventures LLC Director - [D] | 300.000 | 3.471.752 | |
| Bryan Ball See remarks - [O] | 397.106 | 397.106 | |
| Caley Castelein Director - [D] | 2.165.998 | 2.165.998 | |
| Cheryl Cohen Director - [D] | 16.160 | 16.160 | |
| Dhaval Desai Chief Strategy Officer - [O] | 150.684 | 150.684 | |
| Anupam Dalal Director - [D] | 3.411.532 | 3.411.532 | |
| Brendan Delaney Chief Operating Officer - [O] | 20.000 | 20.000 | |
| Neil Desai EXECUTIVE CHAIRMAN, Director - [D] [O] | 1.171.543 | 1.171.543 | |
| Pravin Dugel Director - [D] | 12.568 | 12.568 | |
| Gardner Joseph H. President, Director - [D] [O] | 453.019 | 453.019 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Giacobello Scott M. CHIEF FINANCIAL OFFICER - [O] | 295.224 | 295.224 | |
| Stephen J Hoffman Chief Executive Officer, Director - [D] [O] | 31.967 | 31.967 | |
| Hehenberger Karin M. | 17.549 | ||
|
Samuel D Isaly
Director, 10% Owner -
[D]
|
7.306.902 | 4.416.446 | |
| Lorettta M Itri Chief Medical Officer - [O] | 3.000 | 3.000 | |
|
Chau Quang Khuong
Director, 10% Owner -
[D]
|
5.193.946 | 5.193.946 | |
| David James Lennon CHIEF EXECUTIVE OFFICER, Director - [D] [O] | 518.622 | 518.622 | |
| James B Murphy | 0 | ||
| Regina Marek Vice President of Finance - [O] | 23.250 | 23.250 | |
| Richard E Maroun | 17.549 | ||
|
Ag Novartis
10% Owner -
|
4.049.804 | 4.049.804 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Bioventures Ltd Novartis
10% Owner -
|
4.049.804 | 4.049.804 | |
|
Orbimed Advisors Llc
10% Owner -
|
0 | 0 | |
|
OrbiMed Capital GP V LLC
Director, 10% Owner -
[D]
|
0 | 0 | |
| Steve Pakola | 125.000 | ||
| Peters Kevin G. Chief Scientific Officer - [O] | 320.536 | 320.536 | |
| Steven Prelack Director - [D] | 24.485 | 24.485 | |
| Michael W Rogers | 430.500 | ||
| Emma Reeve | 16.486 | ||
|
Muneer A Satter
Director, 10% Owner -
[D]
|
5.621.835 | 5.621.835 | |
| Paul M Weiss Director - [D] | 2.607.730 | 2.607.730 | |
| Baiteng Zhao Director - [D] | 1.250.000 | 1.250.000 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i WHWK / Whitehawk Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i WHWK / Whitehawk Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | 2026-04-16 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 4,1300 | -141.600 | -585 | 295.224 | ||||
| 2026-04-17 | 2026-04-15 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 3,8600 | -77.000 | -297 | 436.824 | ||||
| 2026-04-15 | 2026-04-14 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,6400 | -92.460 | -337 | 397.106 | ||||
| 2026-04-15 | 2026-04-13 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,4600 | -26.389 | -91 | 489.566 | ||||
| 2026-04-13 | 2026-04-10 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,4300 | -6.596 | -23 | 515.955 | ||||
| 2026-04-13 | 2026-04-09 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,5700 | -50.000 | -178 | 522.551 | ||||
| 2026-04-10 | 2026-04-09 | 4 | Lennon David James | WHWK | Common Stock | D | 3,3800 | -14.500 | -49 | 518.622 | ||||
| 2026-04-08 | 2026-04-08 | 4 | Lennon David James | WHWK | Common Stock | D | 3,4000 | -63.945 | -217 | 533.122 | ||||
| 2026-04-08 | 2026-04-07 | 4 | Lennon David James | WHWK | Common Stock | D | 3,4300 | -94.087 | -323 | 597.067 | ||||
| 2026-04-08 | 2026-04-06 | 4 | Lennon David James | WHWK | Common Stock | D | 3,5100 | -102.395 | -359 | 691.154 | ||||
| 2026-04-03 | 2026-04-01 | 4 | BALL BRYAN | WHWK | Common Stock | D | 366.532 | 572.551 | ||||||
| 2026-04-03 | 2026-04-01 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 473.902 | 502.002 | ||||||
| 2026-04-03 | 2026-04-02 | 4 | Lennon David James | WHWK | Common Stock | D | 3,4800 | -26.858 | -93 | 793.549 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Lennon David James | WHWK | Common Stock | D | 775.828 | 820.407 | ||||||
| 2026-03-10 | 2026-03-02 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,3096 | -1.834 | -6 | 206.019 | ||||
| 2026-03-10 | 2026-03-01 | 4 | BALL BRYAN | WHWK | Common Stock | D | 5.000 | 207.853 | ||||||
| 2026-03-10 | 2026-03-02 | 4 | Lennon David James | WHWK | Common Stock | D | 3,3096 | -5.100 | -17 | 44.579 | ||||
| 2026-03-10 | 2026-03-01 | 4 | Lennon David James | WHWK | Common Stock | D | 16.250 | 49.679 | ||||||
| 2026-03-10 | 2026-03-02 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 3,3096 | -2.594 | -9 | 28.100 | ||||
| 2026-03-10 | 2026-03-01 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 6.750 | 30.694 | ||||||
| 2025-03-05 | 2025-03-04 | 4 | Dalal Anupam | AADI | Common Stock | I | 2,4000 | 1.561.000 | 3.746 | 3.410.402 | ||||
| 2025-03-04 | 2025-03-04 | 4 | Castelein Caley | AADI | Common Stock | I | 2,4000 | 1.666.000 | 3.998 | 2.165.998 | ||||
| 2025-03-04 | 2025-03-04 | 4 | Zhao Baiteng | AADI | Common Stock | I | 2,4000 | 1.250.000 | 3.000 | 1.250.000 | ||||
| 2025-03-04 | 2025-03-04 | 4 | BALL BRYAN | AADI | Common Stock | D | 2,4000 | 100.000 | 240 | 202.853 | ||||
| 2025-03-04 | 2025-03-03 | 4 | BALL BRYAN | AADI | Common Stock | D | 2,3500 | -2.147 | -5 | 102.853 | ||||
| 2025-03-04 | 2025-03-01 | 4 | BALL BRYAN | AADI | Common Stock | D | 5.000 | 105.000 | ||||||
| 2025-03-03 | 2025-03-03 | 4 | Giacobello Scott M. | AADI | Common Stock | D | 2,3500 | -2.806 | -7 | 23.944 | ||||
| 2025-03-03 | 2025-03-01 | 4 | Giacobello Scott M. | AADI | Common Stock | D | 6.750 | 26.750 | ||||||
| 2025-03-03 | 2025-03-03 | 4 | Lennon David James | AADI | Common Stock | D | 2,3500 | -5.690 | -13 | 33.429 | ||||
| 2025-03-03 | 2025-03-01 | 4 | Lennon David James | AADI | Common Stock | D | 16.250 | 39.119 | ||||||
| 2024-10-03 | 2024-10-03 | 4 | Lennon David James | AADI | Common Stock | D | 1,9400 | -9.689 | -19 | 22.869 | ||||
| 2024-10-03 | 2024-10-02 | 4 | Lennon David James | AADI | Common Stock | D | 32.558 | 32.558 | ||||||
| 2024-09-05 | 2024-09-03 | 4 | Desai Neil | AADI | Common Stock | I | 1,7079 | -40.000 | -68 | 1.171.543 | ||||
| 2024-08-05 | 2024-08-05 | 4 | Desai Neil | AADI | Common Stock | I | 1,3437 | -5.652 | -8 | 1.211.543 | ||||
| 2024-08-05 | 2024-08-02 | 4 | Desai Neil | AADI | Common Stock | I | 1,4105 | -18.933 | -27 | 1.217.195 | ||||
| 2024-08-05 | 2024-08-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,4956 | -15.415 | -23 | 1.236.128 | ||||
| 2024-07-02 | 2024-07-02 | 4 | Desai Neil | AADI | Common Stock | I | 1,3421 | -8.652 | -12 | 1.251.543 | ||||
| 2024-07-02 | 2024-07-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,4548 | -31.348 | -46 | 1.260.195 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Desai Neil | AADI | Common Stock | I | 1,7674 | -20.225 | -36 | 1.291.543 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Desai Neil | AADI | Common Stock | I | 1,8086 | -19.775 | -36 | 1.311.768 | ||||
| 2024-05-01 | 2024-05-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,9296 | -40.000 | -77 | 1.331.543 | ||||
| 2024-04-26 | 3 | BALL BRYAN | AADI | Common Stock | D | 100.000 | ||||||||
| 2024-04-03 | 2024-04-02 | 4 | Desai Neil | AADI | Common Stock | I | 2,2275 | -22.228 | -50 | 1.371.543 | ||||
| 2024-04-03 | 2024-04-01 | 4 | Desai Neil | AADI | Common Stock | I | 2,3127 | -17.772 | -41 | 1.393.771 | ||||
| 2024-03-04 | 2024-03-04 | 4 | Desai Neil | AADI | Common Stock | I | 2,0994 | -14.964 | -31 | 1.411.543 | ||||
| 2024-03-04 | 2024-03-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,9687 | -27.036 | -53 | 1.426.507 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,7445 | -42.000 | -73 | 1.453.543 | ||||
| 2024-01-02 | 2024-01-02 | 4 | Desai Neil | AADI | Common Stock | I | 2,0607 | -42.000 | -87 | 1.495.543 | ||||
| 2023-12-07 | 2023-12-06 | 4 | Desai Neil | AADI | Common Stock | I | 4,8194 | -7.037 | -34 | 1.537.543 | ||||
| 2023-12-05 | 2023-12-05 | 4 | Desai Neil | AADI | Common Stock | I | 5,0153 | -15.740 | -79 | 1.544.580 | ||||
| 2023-12-05 | 2023-12-04 | 4 | Desai Neil | AADI | Common Stock | I | 5,1477 | -10.876 | -56 | 1.560.320 | ||||
| 2023-12-05 | 2023-12-01 | 4 | Desai Neil | AADI | Common Stock | I | 5,1373 | -8.347 | -43 | 1.571.196 | ||||
| 2023-11-02 | 2023-11-02 | 4 | Desai Neil | AADI | Common Stock | I | 4,4566 | -31.662 | -141 | 1.579.543 | ||||
| 2023-11-02 | 2023-11-01 | 4 | Desai Neil | AADI | Common Stock | I | 4,3185 | -10.338 | -45 | 1.611.205 | ||||
| 2023-10-03 | 2023-10-03 | 4 | Desai Neil | AADI | Common Stock | I | 4,0961 | -16.431 | -67 | 1.621.543 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Desai Neil | AADI | Common Stock | I | 4,3685 | -25.569 | -112 | 1.637.974 | ||||
| 2023-09-06 | 2023-09-06 | 4 | Desai Neil | AADI | Common Stock | I | 5,2928 | -7.111 | -38 | 1.663.543 | ||||
| 2023-09-06 | 2023-09-05 | 4 | Desai Neil | AADI | Common Stock | I | 5,6341 | -21.000 | -118 | 1.670.654 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Desai Neil | AADI | Common Stock | I | 5,9668 | -13.889 | -83 | 1.691.654 | ||||
| 2023-08-03 | 2023-08-02 | 4 | Desai Neil | AADI | Common Stock | I | 5,1970 | -19.290 | -100 | 1.705.543 | ||||
| 2023-08-03 | 2023-08-01 | 4 | Desai Neil | AADI | Common Stock | I | 5,2190 | -22.710 | -119 | 1.724.833 | ||||
| 2023-07-06 | 2023-07-06 | 4 | Desai Neil | AADI | Common Stock | I | 6,2716 | -15.829 | -99 | 1.747.543 | ||||
| 2023-07-06 | 2023-07-05 | 4 | Desai Neil | AADI | Common Stock | I | 6,5471 | -16.171 | -106 | 1.763.372 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Desai Neil | AADI | Common Stock | I | 6,6446 | -10.000 | -66 | 1.779.543 | ||||
| 2023-06-06 | 2023-06-06 | 4 | Desai Neil | AADI | Common Stock | I | 8,1891 | -7.260 | -59 | 1.789.543 | ||||
| 2023-06-05 | 2023-06-05 | 4 | Desai Neil | AADI | Common Stock | I | 8,1096 | -17.315 | -140 | 1.796.803 | ||||
| 2023-06-05 | 2023-06-02 | 4 | Desai Neil | AADI | Common Stock | I | 7,9901 | -12.443 | -99 | 1.814.118 | ||||
| 2023-06-05 | 2023-06-01 | 4 | Desai Neil | AADI | Common Stock | I | 7,9222 | -4.982 | -39 | 1.826.561 | ||||
| 2023-05-05 | 2023-05-04 | 4 | Desai Neil | AADI | Common Stock | I | 7,5682 | -2.305 | -17 | 1.831.543 | ||||
| 2023-05-03 | 2023-05-03 | 4 | Desai Neil | AADI | Common Stock | I | 7,6768 | -7.695 | -59 | 1.833.848 | ||||
| 2023-05-03 | 2023-05-02 | 4 | Desai Neil | AADI | Common Stock | I | 7,4757 | -7.521 | -56 | 1.841.543 | ||||
| 2023-05-03 | 2023-05-01 | 4 | Desai Neil | AADI | Common Stock | I | 7,7983 | -24.479 | -191 | 1.849.064 | ||||
| 2023-04-06 | 2023-04-06 | 4 | Desai Neil | AADI | Common Stock | I | 7,0927 | -12.212 | -87 | 1.873.543 | ||||
| 2023-04-05 | 2023-04-05 | 4 | Desai Neil | AADI | Common Stock | I | 7,2350 | -7.336 | -53 | 1.885.755 | ||||
| 2023-04-05 | 2023-04-04 | 4 | Desai Neil | AADI | Common Stock | I | 7,3029 | -12.869 | -94 | 1.893.091 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Desai Neil | AADI | Common Stock | I | 7,4460 | -9.583 | -71 | 1.905.960 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Castelein Caley | AADI | Common Stock | I | 12,5000 | 240.000 | 3.000 | 499.998 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Dalal Anupam | AADI | Common Stock | I | 12,5000 | 320.000 | 4.000 | 1.849.402 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Delaney Brendan | AADI | Common Stock | D | 12,5000 | 20.000 | 250 | 20.000 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Giacobello Scott M. | AADI | Common Stock | D | 12,5000 | 20.000 | 250 | 20.000 | ||||
| 2022-09-26 | 2022-09-22 | 4 | Aghazadeh Behzad See footnotes | AADI | Common Stock, $0.0001 par value per share ("Common Stock") | I | 12,5000 | 1.260.000 | 15.750 | 3.471.752 | ||||
| 2022-04-05 | 2022-04-01 | 4 | ITRI LORETTTA M | AADI | Stock option (right to buy) | D | 17,24 | 67.300 | 67.300 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Delaney Brendan | AADI | Stock option (right to buy) | D | 17,24 | 61.000 | 61.000 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Giacobello Scott M. | AADI | Stock option (right to buy) | D | 17,24 | 46.400 | 46.400 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Desai Neil | AADI | Stock option (right to buy) | D | 17,24 | 153.300 | 153.300 | |||||
| 2022-03-22 | 2022-03-18 | 4 | Desai Neil | AADI | Common Stock | I | 20,0658 | -3.550 | -71 | 1.915.543 | ||||
| 2021-10-25 | 2021-10-21 | 4 | ITRI LORETTTA M | AADI | Stock option (right to buy) | D | 26,85 | 185.000 | 185.000 | |||||
| 2021-10-25 | 3 | ITRI LORETTTA M By spouse | AADI | Common Stock | I | 3.000 | ||||||||
| 2021-09-22 | 2021-09-20 | 4 | Delaney Brendan | AADI | Stock option (right to buy) | D | 29,09 | 260.000 | 260.000 | |||||
| 2021-09-10 | 2021-09-08 | 4 | Desai Neil | AADI | Stock option (right to buy) | D | 27,67 | 125.000 | 125.000 | |||||
| 2021-09-10 | 2021-09-08 | 4 | Reeve Emma | AADI | Stock option (right to buy) | D | 27,67 | 16.486 | 16.486 | |||||
| 2021-08-31 | 2021-08-27 | 4 | Hehenberger Karin M. | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-31 | 2021-08-27 | 4 | Maroun Richard E | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-31 | 3 | Desai Neil | AADI | Common Stock | I | 1.919.093 | ||||||||
| 2021-08-31 | 3 | Desai Neil | AADI | Common Stock | I | 639.698 | ||||||||
| 2021-08-31 | 2021-08-26 | 4/A | Dalal Anupam | AADI | Common Stock | I | 13,0770 | 1.529.402 | 20.000 | 1.529.402 | ||||
| 2021-08-30 | 2021-08-27 | 4 | Castelein Caley | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-30 | 2021-08-26 | 4 | Castelein Caley | AADI | Common Stock | I | 13,0770 | 259.998 | 3.400 | 259.998 | ||||
| 2021-08-30 | 2021-08-27 | 4 | Dalal Anupam | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-30 | 2021-08-26 | 4 | Dalal Anupam | AADI | Common Stock | I | 13,0770 | 1.529.402 | 20.000 | 1.529.402 | ||||
| 2021-08-30 | 2021-08-27 | 4 | Aghazadeh Behzad | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-30 | 2021-08-26 | 4 | Aghazadeh Behzad See footnotes | AADI | Common Stock, $0.0001 par value per share ("Common Stock") | I | 13,0770 | 1.911.752 | 25.000 | 2.211.752 | ||||
| 2021-08-30 | 3 | Avoro Ventures LLC See footnotes | AADI | Common Stock, par value $0.0001 per share | I | 300.000 | ||||||||
| 2021-07-02 | 2021-06-30 | 4 | Castelein Caley | ARPO | Common Stock | D | 1,5200 | 7.811 | 12 | 295.414 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Prelack Steven | ARPO | Common Stock | D | 1,5200 | 12.334 | 19 | 24.485 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Cohen Cheryl | ARPO | Common Stock | D | 1,5200 | 8.140 | 12 | 16.160 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Dalal Anupam | ARPO | Common Stock | D | 1,5200 | 7.400 | 11 | 16.959 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Dugel Pravin | ARPO | Common Stock | D | 1,5200 | 6.331 | 10 | 12.568 | ||||
| 2021-06-22 | 2021-06-17 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 1,87 | 100.000 | 100.000 | |||||
| 2021-04-02 | 2021-03-31 | 4 | Dalal Anupam | ARPO | Common Stock | D | 1,5430 | 7.290 | 11 | 9.559 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Prelack Steven | ARPO | Common Stock | D | 1,5430 | 12.151 | 19 | 12.151 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Castelein Caley | ARPO | Common Stock | D | 1,5430 | 7.696 | 12 | 287.603 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Dugel Pravin | ARPO | Common Stock | D | 1,5430 | 6.237 | 10 | 6.237 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Cohen Cheryl | ARPO | Common Stock | D | 1,5430 | 8.020 | 12 | 8.020 | ||||
| 2021-02-03 | 2021-02-01 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2021-02-03 | 2021-02-01 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2021-02-03 | 2021-02-01 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2021-02-03 | 2021-02-01 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2020-12-10 | 2020-12-08 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Stock Option (Right to Buy) | I | 0,96 | -21.400 | 0 | |||||
| 2020-12-10 | 2020-12-08 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Common Stock | I | 1,9600 | -21.400 | -42 | 0 | ||||
| 2020-12-10 | 2020-12-08 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Common Stock | I | 0,9600 | 21.400 | 21 | 21.400 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Prelack Steven | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Marek Regina | ARPO | Stock Option (Right to Buy) | D | 0,52 | 93.000 | 93.000 | |||||
| 2020-03-18 | 2020-03-16 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 0,52 | 129.000 | 129.000 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 0,52 | 155.000 | 155.000 | |||||
| 2019-11-06 | 2019-11-04 | 4 | Marek Regina | ARPO | Stock Option (Right to Buy) | D | 0,56 | 44.300 | 44.300 | |||||
| 2019-10-24 | 3 | Marek Regina | ARPO | Common Stock | D | 23.250 | ||||||||
| 2019-10-24 | 3 | Marek Regina | ARPO | Common Stock | D | 23.250 | ||||||||
| 2019-10-24 | 3 | Marek Regina | ARPO | Common Stock | D | 23.250 | ||||||||
| 2019-07-10 | 2019-07-10 | 4 | Gardner Joseph H. | ARPO | Common Stock | D | 0,8147 | 5.000 | 4 | 453.019 | ||||
| 2019-07-08 | 2019-07-03 | 4 | Gardner Joseph H. | ARPO | Common Stock | D | 0,8970 | 5.000 | 4 | 448.019 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Prelack Steven | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Satter Muneer A | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Khuong Chau Quang | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-05-16 | 2019-05-14 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 1,04 | 266.550 | 266.550 | |||||
| 2019-05-16 | 2019-05-14 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 1,04 | 63.250 | 63.250 | |||||
| 2019-05-16 | 2019-05-14 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 1,04 | 430.500 | 430.500 | |||||
| 2019-05-16 | 2019-05-14 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 1,04 | 169.500 | 169.500 | |||||
| 2019-05-16 | 2019-05-14 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 1,04 | 349.350 | 349.350 | |||||
| 2019-05-16 | 2019-05-14 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 1,04 | 709.050 | 709.050 | |||||
| 2019-04-29 | 2019-04-26 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -138.704 | -143 | 4.049.804 | ||||
| 2019-04-29 | 2019-04-25 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -563.096 | -580 | 4.188.508 | ||||
| 2019-04-24 | 2019-04-24 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -16.403 | -17 | 4.751.604 | ||||
| 2019-04-24 | 2019-04-23 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -27.554 | -28 | 4.768.007 | ||||
| 2019-04-24 | 2019-04-22 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9700 | -7.100 | -7 | 4.795.561 | ||||
| 2019-04-15 | 2019-04-15 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9900 | -28.794 | -29 | 4.802.661 | ||||
| 2019-04-15 | 2019-04-12 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0400 | -30.908 | -32 | 4.831.455 | ||||
| 2019-04-15 | 2019-04-11 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0800 | -57.438 | -62 | 4.862.363 | ||||
| 2019-04-10 | 2019-04-10 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0900 | -140.230 | -153 | 4.919.801 | ||||
| 2019-04-10 | 2019-04-09 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0100 | -32.991 | -33 | 5.060.031 | ||||
| 2019-04-10 | 2019-04-08 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0200 | -27.525 | -28 | 5.093.022 | ||||
| 2019-04-05 | 2019-04-05 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0200 | -24.661 | -25 | 5.120.547 | ||||
| 2019-04-05 | 2019-04-04 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0100 | -47.900 | -48 | 5.145.208 | ||||
| 2019-04-05 | 2019-04-03 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9600 | -58.033 | -56 | 5.193.108 | ||||
| 2019-04-02 | 2019-04-02 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9700 | -51.754 | -50 | 5.251.141 | ||||
| 2019-04-02 | 2019-04-01 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9500 | -116.909 | -111 | 5.302.895 | ||||
| 2019-04-02 | 2019-03-29 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9100 | -63.100 | -57 | 5.419.804 | ||||
| 2019-03-28 | 2019-03-28 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9400 | -88.835 | -84 | 5.482.904 | ||||
| 2019-03-28 | 2019-03-27 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9900 | -50.749 | -50 | 5.571.739 | ||||
| 2019-03-28 | 2019-03-26 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0100 | -177.762 | -180 | 5.622.488 | ||||
| 2019-02-20 | 2019-02-15 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 3,27 | 215.328 | 215.328 | |||||
| 2019-02-20 | 2019-02-15 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 3,27 | 125.000 | 125.000 | |||||
| 2019-02-20 | 2019-02-15 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 3,27 | 365.000 | 365.000 | |||||
| 2019-02-20 | 2019-02-15 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 3,27 | 150.000 | 150.000 | |||||
| 2019-02-20 | 2019-02-15 | 4 | PAKOLA STEVE | ARPO | Stock Option (Right to Buy) | D | 3,27 | 125.000 | 125.000 | |||||
| 2019-02-13 | 2018-12-12 | 5 | Gardner Joseph H. | ARPO | Common Stock | I | 150.000 | 150.000 | ||||||
| 2019-02-13 | 2018-12-12 | 5 | Gardner Joseph H. | ARPO | Common Stock | D | -150.000 | 443.019 | ||||||
| 2019-01-10 | 2019-01-10 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,4537 | 23.818 | 58 | 5.621.835 | ||||
| 2019-01-10 | 2019-01-09 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,3938 | 20.000 | 48 | 5.598.017 | ||||
| 2019-01-10 | 2019-01-08 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1986 | 20.000 | 44 | 5.578.017 | ||||
| 2019-01-07 | 2019-01-07 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1779 | 20.000 | 44 | 5.558.017 | ||||
| 2019-01-07 | 2019-01-04 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1198 | 20.000 | 42 | 5.538.017 | ||||
| 2019-01-07 | 2019-01-03 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0754 | 20.000 | 42 | 5.518.017 | ||||
| 2019-01-02 | 2019-01-02 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9419 | 20.000 | 39 | 5.498.017 | ||||
| 2019-01-02 | 2018-12-31 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,7450 | 20.000 | 35 | 5.478.017 | ||||
| 2019-01-02 | 2018-12-28 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,7186 | 20.000 | 34 | 5.458.017 | ||||
| 2018-12-27 | 2018-12-27 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,6705 | 20.000 | 33 | 5.438.017 | ||||
| 2018-12-27 | 2018-12-26 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,6927 | 20.000 | 34 | 5.418.017 | ||||
| 2018-12-27 | 2018-12-21 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,8435 | 20.000 | 37 | 5.398.017 | ||||
| 2018-12-20 | 2018-12-20 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,8492 | 20.000 | 37 | 5.378.017 | ||||
| 2018-12-20 | 2018-12-19 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9192 | 20.000 | 38 | 5.358.017 | ||||
| 2018-12-20 | 2018-12-18 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9928 | 20.000 | 40 | 5.338.017 | ||||
| 2018-12-14 | 2018-12-14 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0047 | 20.000 | 40 | 5.318.017 | ||||
| 2018-12-14 | 2018-12-13 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0154 | 20.000 | 40 | 5.298.017 | ||||
| 2018-12-14 | 2018-12-12 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0469 | 20.000 | 41 | 5.278.017 | ||||
| 2018-12-11 | 2018-12-11 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0923 | 20.000 | 42 | 5.258.017 | ||||
| 2018-12-11 | 2018-12-10 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1304 | 20.000 | 43 | 5.238.017 | ||||
| 2018-12-11 | 2018-12-07 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1394 | 20.000 | 43 | 5.218.017 | ||||
| 2018-12-06 | 2018-12-06 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1792 | 20.000 | 44 | 5.198.017 | ||||
| 2018-12-06 | 2018-12-04 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0997 | 20.000 | 42 | 5.178.017 | ||||
| 2018-12-06 | 2018-12-03 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9887 | 20.000 | 40 | 5.158.017 | ||||
| 2018-11-30 | 2018-11-30 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9846 | 20.000 | 40 | 5.138.017 | ||||
| 2018-11-30 | 2018-11-29 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0059 | 20.000 | 40 | 5.118.017 | ||||
| 2018-11-30 | 2018-11-28 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9357 | 20.000 | 39 | 5.098.017 | ||||
| 2018-11-16 | 2018-10-26 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 2,05 | 2.500 | 2.500 | |||||
| 2018-11-14 | 2018-11-12 | 4 | HOFFMAN STEPHEN J | ARPO | Common Stock | D | 2,0100 | 30.000 | 60 | 31.967 | ||||
| 2018-11-14 | 2018-11-09 | 4 | HOFFMAN STEPHEN J | ARPO | Common Stock | D | 1,9500 | 1.967 | 4 | 1.967 | ||||
| 2018-09-26 | 2018-09-24 | 4 | Castelein Caley | ARPO | Common Stock | I | -1.603.526 | 0 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Castelein Caley | ARPO | Common Stock | D | 268.987 | 279.907 | ||||||
| 2018-08-22 | 2018-08-20 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 3,9000 | -5.300 | -21 | 5.800.250 | ||||
| 2018-07-02 | 2018-06-28 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Common Stock | I | 3,8500 | 777.500 | 2.993 | 5.193.946 | ||||
| 2018-07-02 | 2018-06-28 | 4 | Khuong Chau Quang See Footnotes | ARPO | Common Stock | I | 3,8500 | 777.500 | 2.993 | 5.193.946 | ||||
| 2018-06-29 | 2018-06-28 | 4 | Satter Muneer A | ARPO | Common Stock | I | 3,8500 | 1.818.182 | 7.000 | 5.078.017 | ||||
| 2018-06-22 | 2018-06-20 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Satter Muneer A | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Prelack Steven | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Khuong Chau Quang | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 4,00 | 42.800 | 42.800 | |||||
| 2018-05-21 | 3 | DESAI DHAVAL | ARPO | Common Stock | D | 150.684 | ||||||||
| 2018-05-21 | 3 | DESAI DHAVAL | ARPO | Common Stock | D | 150.684 | ||||||||
| 2018-05-21 | 3 | DESAI DHAVAL | ARPO | Common Stock | D | 150.684 | ||||||||
| 2018-04-25 | 2018-04-23 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 3,59 | 150.000 | 150.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | PAKOLA STEVE | ARPO | Stock Option (Right to Buy) | D | 3,59 | 100.000 | 100.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 3,59 | 144.000 | 144.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 3,59 | 100.000 | 100.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 3,59 | 300.000 | 300.000 | |||||
| 2018-03-23 | 2018-03-23 | 4 | Satter Muneer A | ARPO | Common Stock | I | 5,0000 | 1.000 | 5 | 3.259.835 | ||||
| 2018-03-23 | 2018-03-21 | 4 | Satter Muneer A | ARPO | Common Stock | I | 4,8475 | 4.000 | 19 | 3.258.835 | ||||
| 2018-03-21 | 2018-03-20 | 4 | Satter Muneer A | ARPO | Common Stock | I | 4,9741 | 5.400 | 27 | 3.254.835 | ||||
| 2018-03-21 | 2018-03-19 | 4 | Satter Muneer A | ARPO | Common Stock | I | 4,9638 | 7.600 | 38 | 3.249.435 | ||||
| 2018-02-14 | 2017-12-22 | 5 | Dalal Anupam | ARPO | Common Stock | D | 2.269 | 2.269 | ||||||
| 2018-02-14 | 2017-12-22 | 5 | Dalal Anupam | ARPO | Common Stock | I | -7.882 | 0 | ||||||
| 2018-02-14 | 2017-12-22 | 5 | Castelein Caley | ARPO | Common Stock | I | 10.920 | 10.920 | ||||||
| 2018-02-14 | 2017-12-22 | 5 | Castelein Caley | ARPO | Common Stock | I | -7.882 | 1.603.526 | ||||||
| 2017-12-18 | 2017-12-14 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 5,50 | 5,5000 | 293.006 | 1.612 | 0 | |||
| 2017-12-18 | 2017-12-14 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 5,50 | 5,5000 | 135.000 | 742 | 0 | |||
| 2017-12-18 | 2017-12-14 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 5,50 | 5,5000 | 586.012 | 3.223 | 0 | |||
| 2017-03-17 | 3 | Khuong Chau Quang See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | Khuong Chau Quang See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | PETERS KEVIN G. | NONE | Common Stock | D | 633.788 | ||||||||
| 2017-03-17 | 3 | PETERS KEVIN G. | NONE | Common Stock | D | 633.788 | ||||||||
| 2017-03-17 | 3 | Dalal Anupam | NONE | Common Stock | I | 15.764 | ||||||||
| 2017-03-17 | 3 | Dalal Anupam | NONE | Common Stock | I | 15.764 | ||||||||
| 2017-03-17 | 3 | Gardner Joseph H. | NONE | Common Stock | D | 986.046 | ||||||||
| 2017-03-17 | 3 | Gardner Joseph H. | NONE | Common Stock | D | 986.046 | ||||||||
| 2017-03-17 | 3 | Castelein Caley See Footnotes | NONE | Common Stock | I | 2.422.816 | ||||||||
| 2017-03-17 | 3 | Castelein Caley See Footnotes | NONE | Common Stock | I | 2.422.816 | ||||||||
| 2017-03-17 | 3 | WEISS PAUL M See Footnotes | NONE | Common Stock | I | 2.607.730 | ||||||||
| 2017-03-17 | 3 | WEISS PAUL M See Footnotes | NONE | Common Stock | I | 2.607.730 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | NOVARTIS AG | NONE | Common Stock | I | 10.491.100 | ||||||||
| 2017-03-17 | 3 | NOVARTIS AG | NONE | Common Stock | I | 10.491.100 | ||||||||
| 2017-03-17 | 3 | NOVARTIS AG | NONE | Common Stock | I | 10.491.100 | ||||||||
| 2017-03-17 | 3 | Satter Muneer A | NONE | Common Stock | I | 4.243.670 | ||||||||
| 2017-03-17 | 3 | Satter Muneer A | NONE | Common Stock | I | 4.243.670 | ||||||||
| 2017-03-17 | 2017-03-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | NONE | Common Stock | I | 5,0000 | 762.995 | 3.815 | 4.416.446 | ||||
| 2017-03-17 | 2017-03-15 | 4 | PETERS KEVIN G. | NONE | Common Stock | D | 5,0000 | 3.642 | 18 | 320.536 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Khuong Chau Quang See Footnotes | NONE | Common Stock | I | 5,0000 | 762.995 | 3.815 | 4.416.446 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Castelein Caley | NONE | Common Stock | I | 5,0000 | 400.000 | 2.000 | 1.611.408 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Novartis Bioventures Ltd | NONE | Common Stock | I | 5,0000 | 560.000 | 2.800 | 5.805.550 | ||||
| 2017-03-17 | 2017-03-15 | 4 | WEISS PAUL M See Footnotes | NONE | Common Stock | I | 5,0000 | 272.302 | 1.362 | 1.576.167 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Gardner Joseph H. | NONE | Common Stock | D | 5,0000 | 99.996 | 500 | 593.019 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Satter Muneer A | NONE | Common Stock | I | 5,0000 | 1.120.000 | 5.600 | 3.241.835 |
